Stereotactic Body Radiotherapy for Head and Neck Tumors
STATEMENT OF NEED
The role of stereotactic body radiotherapy (SBRT) as a therapeutic option for the treatment of head and neck tumors is continuously evolving. SBRT has been shown to achieve effective local control when used as a boost after external beam radiation for the treatment of head and neck tumors. SBRT has also been used as a primary local therapy in medically inoperable patients and is used as a salvage therapy for recurrent head and neck cancers. Significant challenges are involved when delivering radiation to the head and neck region and there is a need to further improve the toxicity profile following radiation therapy. The optimal dose, fractionation and duration of SBRT need to be further defined as well as exploring the combination of biological approaches to maximize the impact of radiation treatment for head and neck tumors.
This program is designed to meet the needs of radiation oncologists and residents-in-training with interests in SBRT for the treatment of head and neck tumors.
A note on browser incompatibility: